Healthcare provider profile · identity verified

Hoa V Le, M.D.

Family Practice · SAINT PETERSBURG, FL · NPI 1699769281

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	705	224
Albuterol Sulfate Hfa	Albuterol Sulfate	606	210
Nitroglycerin	Nitroglycerin	506	295
Metoprolol Succinate	Metoprolol Succinate	403	146
Lisinopril	Lisinopril	372	133
Atorvastatin Calcium	Atorvastatin Calcium	347	121
Metformin Hcl	Metformin Hcl	338	104
Gabapentin	Gabapentin	326	113
Meloxicam	Meloxicam	307	100
Donepezil Hcl	Donepezil Hcl	254	88
Amlodipine Besylate	Amlodipine Besylate	252	93
Prednisone	Prednisone	241	151
Omeprazole	Omeprazole	218	76
Losartan Potassium	Losartan Potassium	197	63
Sertraline Hcl	Sertraline Hcl	196	75
Montelukast Sodium	Montelukast Sodium	157	56
Levothyroxine Sodium	Levothyroxine Sodium	155	46
Fluticasone Propionate	Fluticasone Propionate	153	48
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	143	35
Carvedilol	Carvedilol	136	42
Tamsulosin Hcl	Tamsulosin Hcl	123	38
Trazodone Hcl	Trazodone Hcl	123	41
Pantoprazole Sodium	Pantoprazole Sodium	116	41
Tramadol Hcl	Tramadol Hcl	111	40
Triamcinolone Acetonide	Triamcinolone Acetonide	106	48
Wixela Inhub	Fluticasone Propion/Salmeterol	106	22
Baclofen	Baclofen	104	51
Azithromycin	Azithromycin	103	76
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	101	26
Vitamin D2	Ergocalciferol (Vitamin D2)	94	36
Famotidine	Famotidine	91	30
Glipizide	Glipizide	91	34
Hydrochlorothiazide	Hydrochlorothiazide	86	31
Metoprolol Tartrate	Metoprolol Tartrate	85	30
Valsartan	Valsartan	81	23
Furosemide	Furosemide	77	30
Ibuprofen	Ibuprofen	75	25
Clopidogrel	Clopidogrel Bisulfate	69	20
Potassium Chloride	Potassium Chloride	63	27
Alendronate Sodium	Alendronate Sodium	62	21
Escitalopram Oxalate	Escitalopram Oxalate	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	20
Metoclopramide Hcl	Metoclopramide Hcl	59	21
Simvastatin	Simvastatin	58	20
Eliquis	Apixaban	56	16
Meclizine Hcl	Meclizine Hcl	56	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	17
Levofloxacin	Levofloxacin	53	42
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	46
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	18
Ondansetron Hcl	Ondansetron Hcl	51	17
Tizanidine Hcl	Tizanidine Hcl	50	13
Pioglitazone Hcl	Pioglitazone Hcl	49	14
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Fenofibrate	Fenofibrate,micronized	48	12
Finasteride	Finasteride	47	16
Clonazepam	Clonazepam	45	suppressed
Methylprednisolone	Methylprednisolone	45	30
Spironolactone	Spironolactone	45	17
Ventolin Hfa	Albuterol Sulfate	45	29
Hydroxyzine Hcl	Hydroxyzine Hcl	44	13
Oxybutynin Chloride	Oxybutynin Chloride	44	14
Pravastatin Sodium	Pravastatin Sodium	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Memantine Hcl	Memantine Hcl	40	suppressed
Clobetasol Propionate	Clobetasol Propionate	35	11
Mirtazapine	Mirtazapine	35	suppressed
Allopurinol	Allopurinol	34	12
Celecoxib	Celecoxib	31	suppressed
Atenolol	Atenolol	30	suppressed
Azelastine Hcl	Azelastine Hcl	30	12
Lorazepam	Lorazepam	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	28	12
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Cephalexin	Cephalexin	26	24
Glimepiride	Glimepiride	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Fenofibrate	Fenofibrate	23	suppressed
Naproxen	Naproxen	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Ketoconazole	Ketoconazole	22	13
Megestrol Acetate	Megestrol Acetate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Metronidazole	Metronidazole	21	17
Mupirocin	Mupirocin	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Amoxicillin	Amoxicillin	19	15
Latanoprost	Latanoprost	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	18
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Nystatin	Nystatin	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Topiramate	Topiramate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Klor-Con 10	Potassium Chloride	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lactulose	Lactulose	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Metolazone	Metolazone	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error